I Rapporti regionali 2024 AIFA offrono una lettura territoriale dell’uso dei farmaci in Italia. Consumi stabili, spesa in crescita e forti differenze tra regioni delineano un sistema sotto controllo, ma ancora disomogeneo.

Secondo il report “AI Adoption Gap in Healthcare”, il 78% delle aziende MedTech italiane integra già l’intelligenza artificiale, ma l’adozione nel Servizio Sanitario resta limitata. Le barriere non sono tecnologiche, ma regolatorie, organizzative e culturali. Il nodo diventa quindi industriale e di sistema, più che scientifico.

A novelty in the world of biomaterials

Genenta announces Long-Term follow-up observations in brain tumor (GBM) study with emerging survival signals

The October issue of MakingPharmaIndustry accompanies CPhI Frankfurt 2025, showcasing how research, technology, and industry are reshaping the future of Pharma. From advanced therapies to sustainable manufacturing, from AI to regulatory quality, the tabloid explores the people, ideas, and innovations driving a new era of global health.

In the March multimedia magazine, we explore the impact of artificial intelligence and cybersecurity regulations in the pharmaceutical industry. As artificial intelligence reshapes drug development,...